Canadian Thalidomide Survivors Support Program

Important Updates



Thalidomide Survivors Contribution Program Class Proceeding – Notice of Settlement Approval Hearing on February 26-27, 2020. Click here  for more information.


CTSSP Application Deadline:

Step 1 – Preliminary Screening Applications are now available for any living individual who believes that they are a Thalidomide Survivor, including those previously denied under the 1991 EAP or the 2015 TSCP. Click here to download the form or call 1-877-507-7706 (TTY: 1-877-627-7027) to have one sent to you. The CTSSP Application deadline is postmarked by June 3, 2024 to the Administrator.



Confirmed Survivors who are currently at a level 1 or a level 2, may request reassessment of their health status for the 2019-2020 FY anytime between April 1, 2019 and March 31, 2020. Click here to download the application.



EMAF applications are now being accepted for the 2019-2020 FY. Confirmed Survivors may submit up to a maximum of two applications per year anytime between April 1, 2019 and March 31, 2020. Click here to download the application.


You may also call the Administrator at 1-877-507-7706 (TTY: 1-877-627-7027) or by email to to have any of the forms sent to you by mail or email.

Update for January 1, 2020


The annual Outreach Newsletter for Survivors will be issued in February to Confirmed Survivors by each person’s preferred method of communication (email or mail).  If you prefer to receive correspondence by email, please ensure that is added to your address book to ensure you receive the newsletter.


Following the newsletter, the Administrator will send you a brief survey to complete. Your comments about the CTSSP will help us identify areas in the process where adjustments may be beneficial.


You will be able to complete the survey online, via email, by phone or by mail.


Next status update will be February 1, 2020.


December 1, 2019


Delivery of the Step 2 application form to CTSSP Applicants, who have been approved at Step 1, is pending the release of the Diagnostic Algorithm for Thalidomide embryopathy which will be utilized at Step 2 to help assess the probability that an individual’s congenital malformations are consistent with known patterns of Thalidomide embryopathy. It is important to ensure that the information requested on the Step 2 application form will be pertinent to the algorithm.


Further updates regarding the status of the release of the algorithm will be posted here as they become available.


We thank you for your patience.


The next status update will be January 1, 2020.


November 1, 2019


For individuals who are submitting Step 1 – Preliminary Screening applications, please complete the application form in its entirety. If you previously applied for the Thalidomide Survivors Contribution Program and would like us to review the supporting documentation submitted to the Administrator at that time, please indicate that on the Step 1 Application form.


Providing us with as much information as possible about your injuries, including descriptive comments within the application, photographs of your injuries and letters from family members and others who may have knowledge of your mother’s ingestion of Thalidomide are extremely helpful. Medical documents are also helpful, but not required at this step of the process.


Proof of identification is required for all claimants.  Legally appointed representatives must provide identification for both the CTSSP applicant and the representative (if applicable). It is preferred that the identification submitted for the CTSSP applicant include the individual’s date and country of birth.


The next status updated will be December 1, 2019


October 2019


Individuals who have already been recognized as Confirmed Survivors under the former 2015 TSCP program may request reconsideration at any time during the 2019-2020 FY if they are currently at Level 1 or 2. Any change to your disability level as a result of your request for reassessment will take effect the following fiscal year.


Confirmed Survivors may also request additional funding for home or vehicle improvements or specialized surgeries by submitting an EMAF application. EMAF applications are accepted throughout the year and will be processed as they are submitted.


Claimants who have not yet been recognized as Confirmed Survivors under the new Canadian Thalidomide Survivors Support Program may submit an application any time prior to June 3, 2024. For those individuals who have received positive decision letters at Step 1 of the application process, you should be receiving the Step 2 application shortly.


The next status update will be November 1, 2019.


September 19, 2019

Review of Step 1 – Preliminary Screening applications is underway and it is anticipated that decisions on completed applications will be rendered in writing the near future.


If more information is needed to complete a review of an application, the Administrator will contact the claimant by their preferred method of delivery.


If you have changed your contact information recently, please contact the administrator so that we have the most up to date information for you.


The next status update will be available October 1, 2019.


August 1, 2019


Frequently asked questions and answers pertaining to the application process for Unconfirmed Claimants have added to the FAQ Page of the website.


If you have additional questions, please feel free to contact the Administrator.


The next status update will be September 1, 2019.


July 1, 2019


Effective July 1st, 2019, you may notice that Crawford Class Action Services will have a new name, Epiq Class Action Services. While our name is new, our location and all the familiar voices of our Administration team will remain the same. You may also notice a slight change to our personal email addresses if you email one of us directly. Our personal email addresses will now end in If you have any questions, please feel free to contact the Administrator.


The next status update will be August 1, 2019.


June 1, 2019


74 Confirmed Survivors responded to the 2018-2019 FY Outreach Survey. Thank you to everyone who was able to respond to the survey prior to the Survey Response deadline.


Some highlights from your responses to the Survey are as follows:


  • The majority of Survivors reported that their physical and functional health has declined since the last survey; however, a few Survivors reported their health has improved   and a number of Survivors indicated that their health has remained the same.

  • The majority of Survivors reported that they use their Ongoing Support Payment to fund ongoing treatments/prescriptions that are not otherwise covered.

  • The majority of Survivors indicated that the EMAF funding that they have received has been helpful in their ability to age with dignity.

  • The majority of Survivors believe that increasing the EMAF cap by 2% per fiscal year is a positive change.

  • The majority of Survivors who contacted the Administrator by email or by telephone this past year rated the level of service received as very helpful.


The CTSSP reviews and considers all question responses in an effort to continuously strive to improve the program to meet Confirmed Survivor needs within the program parameters.


The next Confirmed Survivor Outreach Survey will be issued in February of 2020.


The next status update will be available July 2, 2019.


Need Help